Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-HALOPERIDOL | 0.5MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167168 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2022-09-07 | 2023-10-05 | 168733 |
| TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176836 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2022-12-08 | 2023-04-28 | 177523 |
| TEVA-ALPRAZOLAM | 0.5MG | TABLET | Resolved | 2023-01-12 | 2023-04-28 | 180897 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-02-09 | 2024-05-30 | 184216 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-06-16 | 2023-07-05 | 195164 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Actual shortage | 2023-06-19 | 2024-05-16 | 195478 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195775 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Actual shortage | 2023-07-12 | 2024-02-01 | 198394 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-10-19 | 2024-04-11 | 207548 |
| ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2023-10-26 | 2024-01-11 | 208260 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1691 |
| TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2017-03-14 | 2018-09-13 | 2218 |
| TEVA-RISPERIDONE | 1.0MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42601 |
| ACT PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2018-09-06 | 2019-04-11 | 60129 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2019-06-27 | 2019-08-29 | 87665 |
| TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2019-08-15 | 2019-10-04 | 91645 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2019-11-07 | 2020-05-29 | 98188 |
| TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2020-05-21 | 2020-08-13 | 115547 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |